Tag: Prescription Drugs
ASCO: Osimertinib Improves Progression-Free Survival in EGFR-Mutated Lung Cancer
Significantly longer progression-free survival, but not overall survival, seen for osimertinib in unresectable EGFR-mutation NSCLC
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma
Neoadjuvant treatment followed by surgery results in longer event-free survival for resectable, macroscopic stage III melanoma
ASCO: Asciminib Has Superior Efficacy to TKIs for Newly Diagnosed Leukemia
More patients receiving asciminib than investigator-selected tyrosine kinase inhibitor had major molecular response at 48 weeks
Racial Disparity Seen in Naloxone Administration
Finding seen among Black people with overdose deaths in Pennsylvania versus White people
1.5 Percent Ruxolitinib Cream Safe, Effective for Teens With Eczema
Ruxolitinib cream well tolerated, and disease control maintained over a year with as-needed use
Bimekizumab Yields Meaningful Response in Hidradenitis Suppurativa
Rapid clinically meaningful response seen, which was maintained for 48 weeks for moderate-to-severe hidradenitis suppurativa
Some Healthy Teens Are Given Cannabidiol for Health Reasons
Odds increase in association with being older, White or Hispanic
In Utero Exposure to Antiseizure Meds Does Not Affect Child Creativity
In secondary analysis, fetal ASM exposure-dependent effects were seen for executive function at age 4.5 years
Pharmacological Treatment of ADHD May Cut Some Forms of Criminality
Study finds reduction in impulsive-reactive behavior-related crimes but not those with intent or planning
Dupilumab Tied to Fewer Exacerbations in COPD With Type 2 Inflammation
Increase seen in prebronchodilator forced expiratory volume in one second with dupilumab versus placebo at weeks 12, 52